PLYMOUTH, Minn.--(BUSINESS WIRE)--Interrad Medical, a privately held medical device company, announces its SecurAcath device has received an Innovative Technology contract from Vizient, Inc., the ...

SecurAcath (Interrad Medical) is a securement device that uses an anchor below the skin to hold cerebrospinal fluid (CSF) drainage catheters in place. It comprises a base and a cover: the base ...

PLYMOUTH, Minn.--(BUSINESS WIRE)--Interrad Medical, a privately held medical device company, announces the SecurAcath Subcutaneous Catheter Securement Device has been selected for the Innovation and ...

PLYMOUTH, Minn.--(BUSINESS WIRE)--Interrad Medical, a privately held medical device company, announces the SecurAcath is one of only four medical technologies to be included in the new MedTech Funding ...

Interrad Medical has announced it has received FDA clearance for four new sizes of the SecurAcath subcutaneous catheter securement device, according to a news release ...

5.1 The company identified 3 published economic studies, but the external assessment centre considered them to be outside the scope. It did not identify any further economic studies. 5.2 The company ...

The Standards provide the most comprehensive guidance related to the Another important addition to the 2016 Standards for VAD stabilization is a caution to be aware of the risk of medical ...

Interrad Medical, Inc., a privately held medical device company, announces excellent results of a clinical study published in JAMA Pediatrics titled, "Securement to prevent non-cuffed central venous ...

Each year, health care professionals worldwide insert 500 million vascular access catheters into patients’ veins for blood draws or intravenous medications. Traditionally, catheters are attached to ...

Interrad Medical, Inc. a privately held medical device company, announced today that it has raised approximately $10 million in its Series C financing. The funding was raised through a private ...